Stay Informed on Corporate Sustainability

Author: Jed Nykolle Harme

The pharmaceutical and life sciences industry is entering a transformative phase, characterised by strategic realignment and long-term investment in innovation. As global demand grows for advanced therapies and sustainable production, major players are reconfiguring operations to enhance efficiency and scientific output. SGS continues to empower professionals worldwide through its series of expert-led webinars, offering in-depth insights into evolving regulatory expectations, analytical testing challenges, and global industry best practices. The US Food and Drug Administration (FDA) has announced new measures to accelerate the approval of biosimilar medicines, generic versions of complex biologics engineered from living cells, marking a major shift in the pharmaceutical landscape. Meanwhile, Kuehne+Nagel named title sponsor for Pharma Industry Awards 2025 highlights how collaboration between healthcare logistics and life sciences continues to strengthen sector-wide innovation and recognition. These developments illustrate an industry balancing progress with precision, advancing innovation while ensuring global access and operational excellence. Stay connected to the ideas shaping the future of pharma, explore the full stories in this edition of our newsletter.

Author: Jed Nykolle Harme

The Pharma Industry Awards 2025 proudly welcomes Kuehne+Nagel Ireland as this year’s Title Sponsor, underscoring the company’s long-standing commitment to advancing excellence and innovation within the pharmaceutical and life sciences sectors.

Author: Contract Pharma

Bora Pharmaceuticals partners with Accord BioPharma to manufacture pre-filled syringes of UDENYCA at its Baltimore facility, expanding U.S. cancer care supply through advanced aseptic fill/finish capabilities.

Author: Bio Pharma Dive

Alkermes to acquire Avadel Pharmaceuticals for $2.1 billion, gaining sleep drug Lumryz and expanding into narcolepsy treatments; deal strengthens position in orexin-based therapies amid competition with Takeda’s oveporexton.

Author: Oceanographic Magazine

UCD leads €1.5M BRICONS project to restore Ireland’s native flat oyster reefs, in partnership with ATU, QUB, and TCD, aiming to boost biodiversity and coastal resilience under the Marine Institute’s Marine Research Programme.

Author: Fierce Pharma

Merck KGaA to close its Arklow, Ireland plant by 2028, cutting 100 jobs after discontinuing API production, while expanding €150 million filtration manufacturing operations in Cork under MilliporeSigma.

Author: Archie Villaflores

At SGS ISL Cork, the commitment to scientific excellence extends beyond the laboratory. To meet the growing demand for skilled professionals, SGS has strengthened its partnership with University College Cork (UCC) to develop future industry leaders through research and mentoring.

Author: Jed Nykolle Harme

Ireland’s biopharmaceutical and chemical industries are among the country’s greatest success stories, driving exports, innovation, and high-value employment. Yet sustaining that success depends on one critical factor: a skilled and adaptable workforce.

Author: Jed Nykolle Harme

The pharma and life sciences industry stands at a pivotal moment, defined by rapid innovation, evolving regulations, and the constant pursuit of excellence. Yet, amid the complexity of scientific advancement, one principle remains clear: progress depends on people. Building a skilled, forward-thinking workforce has become central to sustaining Ireland’s position as a global leader in BioPharmaChem and beyond. Empowering Ireland’s BioPharmaChem Workforce through funded, industry-led training showcases how coordinated investment in education and industry partnerships is reshaping talent pipelines. The initiative reflects a broader commitment to preparing professionals for the next generation of biopharma manufacturing. SGS ISL Cork’s academic collaboration reinforces this vision by nurturing the next wave of scientific leaders through applied research and mentoring. It demonstrates how academia and industry can jointly accelerate innovation. Meanwhile, Alice Redmond’s appointment to the Pharma Industry Awards 2025 Judging Coordinator adds further expertise to a platform that celebrates achievement and drives excellence across the sector. These developments highlight an industry investing deeply in its people, ensuring that Ireland’s leadership in pharma and life sciences continues to grow stronger and more resilient.

Author: Jed Nykolle Harme

With over 30 years of experience in the pharmaceutical, medical device, and biotechnology sectors, Alice Redmond brings unparalleled expertise and leadership to the judging panel of the Pharma Industry Awards 2025.